Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 26.57B | 27.92B | 29.66B | 31.33B | 26.73B |
Gross Profit | 6.85B | 6.62B | 7.01B | 6.52B | 6.04B |
EBITDA | 3.17B | 3.09B | 3.09B | 2.80B | 2.44B |
Net Income | 2.08B | 2.00B | 2.11B | 2.01B | 1.54B |
Balance Sheet | |||||
Total Assets | 33.26B | 32.57B | 31.92B | 31.39B | 31.41B |
Cash, Cash Equivalents and Short-Term Investments | 5.73B | 4.65B | 5.53B | 4.45B | 4.68B |
Total Debt | 4.01B | 4.21B | 5.00B | 5.03B | 5.66B |
Total Liabilities | 11.39B | 11.12B | 11.82B | 12.23B | 13.74B |
Stockholders Equity | 21.86B | 21.45B | 20.10B | 19.16B | 17.67B |
Cash Flow | |||||
Free Cash Flow | 2.80B | 660.00M | 2.50B | 821.00M | 694.00M |
Operating Cash Flow | 2.84B | 717.00M | 2.54B | 886.00M | 887.00M |
Investing Cash Flow | 140.00M | 25.00M | -206.00M | -5.00M | -415.00M |
Financing Cash Flow | -1.90B | -1.63B | -1.25B | -1.11B | -73.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
82 Outperform | ¥88.46B | 4.78 | 14.23% | 1.64% | 6.88% | 19.15% | |
77 Outperform | $98.57B | 35.48 | 4.87% | 1.30% | 7.37% | -47.09% | |
76 Outperform | ¥15.50B | 8.08 | 4.69% | -4.83% | 7.20% | ||
74 Outperform | ¥64.01B | 13.32 | 2.87% | 12.64% | 200.30% | ||
72 Outperform | ¥60.64B | 8.55 | 2.73% | -6.16% | -26.82% | ||
71 Outperform | ¥175.80B | 10.39 | 6.20% | 3.17% | 3.62% | -0.47% | |
48 Neutral | ¥36.24B | ― | 7.27% | -25.73% | 84.97% |